In breast cancer cells, pharmacological, as well as genetic inactivation of SCD1 inhibits tumor cell proliferation and glucose-mediated lipogenesis (Scaglia et al, 2009; Luyimbazi et al, 2010). This evidence concerns the gene SCD and breast carcinoma.